PyrotInib in combination with Capecitabine for trasTUzumab-REsistant, HER2-positive advanced breast cancer (PICTURE): a multicenter phase 2 trial

被引：0
|
作者：
Hu, Xichun
Cao, Jun
Teng, Yue'e
Li, Hui-Ping
Zhang, Lili
Ouyang, Quchang
Xie, Weimin
Pan, Yueyin
Song, Zhenchuan
Ling, Xiaoling
Wu, Xiaohong
Xu, Jingwei
Li, Li
Ren, Liping
Wang, Hong
Zhou, Dongxian
Luo, Jing
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-01-43
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-43
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial
    Min Yan
    Limin Niu
    Huimin Lv
    Mengwei Zhang
    Jing Wang
    Zhenzhen Liu
    Xiuchun Chen
    Zhenduo Lu
    Chongjian Zhang
    Huiai Zeng
    Shengnan Zhao
    Yajing Feng
    Huihui Sun
    Huajun Li
    Nature Communications, 14
  • [42] In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer
    Wang, Hui
    Nie, Caiyun
    Xu, Weifeng
    Li, Jing
    Gou, He
    Lv, Huifang
    Chen, Beibei
    Wang, Jianzheng
    Liu, Yingjun
    He, Yunduan
    Zhao, Jing
    Chen, Xiaobing
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [43] Pyrotinib in combination with trastuzumab and docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer (PHEDRA): A randomized, double-blind, multicenter, phase 3 study
    Wu, Jiong
    Liu, Zhenzhen
    Yang, Hongjian
    Tang, Jinhai
    Wang, Kun
    Liu, Yunjiang
    Wang, Haibo
    Fu, Peifen
    Zhang, Shuqun
    Liu, Qiang
    Jiang, Zefei
    Wang, Shusen
    Huang, Jian
    Wang, Chuan
    Wang, Shu
    Wang, Yongsheng
    Zhen, Linlin
    Zhu, Xiaoyu
    Wu, Fei
    Zhang, Tao
    Zou, Jianjun
    CANCER RESEARCH, 2022, 82 (04)
  • [44] REAL-WORLD DATA OF TRIPLET COMBINATION OF PYROTINIB, TRASTUZUMAB, AND CHEMOTHERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER: A MULTICENTER, RETROSPECTIVE STUDY
    Wang, Biyun
    You, Shuhui
    Xie, Yizhao
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    BREAST, 2023, 71 : S52 - S52
  • [45] Real-world data of triplet combination of pyrotinib, trastuzumab, and chemotherapy in HER2-positive metastatic breast cancer: a multicenter, retrospective study
    You, Shuhui
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    Xie, Yizhao
    Wang, Biyun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [46] Pyrotinib plus trastuzumab versus pertuzumab plus trastuzumab in patients with HER2-positive metastatic breast cancer: A multicenter, retrospective study
    Wang, B.
    You, S.
    Xie, Y.
    Xu, F.
    Sang, D.
    Luo, T.
    Yuan, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S361 - S362
  • [47] Lapatinib plus capecitabine for HER2-positive advanced breast cancer
    Geyer, Charles E.
    Forster, John
    Lindquist, Deborah
    Chan, Stephen
    Romieu, C. Gilles
    Pienkowski, Tadeusz
    Jagiello-Gruszfeld, Agnieszka
    Crown, John
    Chan, Arlene
    Kaufman, Bella
    Skarlos, Dimosthenis
    Campone, Mario
    Davidson, Neville
    Berger, Mark
    Oliva, Cristina
    Rubin, Stephen D.
    Stein, Steven
    Cameron, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26): : 2733 - 2743
  • [48] Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial
    He, Maiyue
    Liu, Jiaxuan
    Wang, Zijing
    Ma, Fei
    Wang, Jiayu
    Zhang, Pin
    Li, Qing
    Yuan, Peng
    Luo, Yang
    Fan, Ying
    Mo, Hongnan
    Lan, Bo
    Li, Qiao
    Xu, Binghe
    BREAST, 2023, 72
  • [49] Epirubicin, cyclophosphamide and pyrotinib followed by docetaxel, trastuzumab and pyrotinib as neoadjuvant therapy for stage II-III HER2-positive breast cancer: a single-arm, multicenter phase 2 trial
    Shi, Qiyun
    Qi, Xiaowei
    Tang, Peng
    Fan, Linjun
    Chen, Li
    Wang, Shushu
    Zhang, Guozhi
    Wang, Mengyuan
    Che, Hongying
    Lv, Pengwei
    Chen, Dejie
    Hu, Jinhui
    Li, Qiuyun
    Zhang, Yanwu
    Yu, Qiao
    Yang, Kunxian
    Zhong, Yuan
    Chen, Chuang
    Zhou, Zemin
    Qian, Liyuan
    Zhang, Jingwei
    Ma, Mingde
    Sun, Yi
    Liu, Jiangbo
    Zhang, Yi
    Jiang, Jun
    CANCER RESEARCH, 2023, 83 (05)
  • [50] Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors
    Jialin Zhang
    Gengshen Yin
    Chunmiao Ye
    Man Feng
    Changhua Ji
    Wenzhong Zhou
    Fei Wang
    Lixiang Yu
    Shuya Huang
    Zhigang Yu
    Chinese Journal of Cancer Research, 2024, 36 (02) : 124 - 140
12345